bovnews2h
Marsh & McLennan Companies Inc (MMC) Stock: Beyond the Surface of Its Performance?
Marsh & McLennan Companies Inc (MMC) stock saw a modest uptick, ending the day at $218.22 which represents a slight increase of $2.99 or 1.39% from the prior close of $215.23. The stock opened at $215 ...
Piper Sandler Remains a Buy on Fifth Third Bancorp (FITB)
In a report released today, Scott Siefers from Piper Sandler maintained a Buy rating on Fifth Third Bancorp (FITB – Research Report), with a ...
RBC Capital Reaffirms Their Buy Rating on The Estée Lauder Companies (EL)
In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report), ...
U.S. stocks close higher amid tech stocks revival
US stocks ended higher on Friday driven by gains in big tech and chip companies The Dow Jones Industrial Average rose 33470 points or 078 perce ...
CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
bovnews6d
Marsh & McLennan Companies Inc (MMC) Stock Sees Market Value Hit $104.41 billion: What Are the Implications?
Marsh & McLennan Companies Inc (MMC) stock saw a decline, ending the day at $212.59 which represents a decrease of $-0.78 or -0.37% from the prior close of $213.37. The stock opened at $214.43 and ...